Ernexa Therapeutics Inc. reports

Company location: Cambridge, MA
Fiscal year end: 31 December

Ernexa Therapeutics Inc. has filed 1,510 SEC EDGAR filings since 14 Feb 1994

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 276-300 of 1,000 matching filings.

Per page

25

Current page

12

SC 13D/A File 005-42217

SC 13 D/A

Filing date: 16 Mar 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 15 Mar 2022
Reporting date: 11 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 15 Mar 2022
Reporting date: 11 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 15 Mar 2022
Reporting date: 11 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 15 Mar 2022
Reporting date: 11 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 15 Mar 2022
Reporting date: 11 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-11460

8-K

Filing date: 09 Mar 2022
Reporting date: 06 Mar 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13G/A File 005-42217

SC 13G/A

Filing date: 16 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-11460

8-K

Filing date: 24 Jan 2022
Reporting date: 18 Jan 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-11460

8-K

Filing date: 20 Jan 2022
Reporting date: 14 Jan 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 19 Jan 2022
Reporting date: 14 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 19 Jan 2022
Reporting date: 14 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 19 Jan 2022
Reporting date: 14 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 19 Jan 2022
Reporting date: 14 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-11460

8-K

Filing date: 05 Jan 2022
Reporting date: 03 Jan 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-11460

8-K

Filing date: 21 Dec 2021
Reporting date: 16 Dec 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 10 Dec 2021
Reporting date: 08 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 10 Dec 2021
Reporting date: 08 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 10 Dec 2021
Reporting date: 08 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 10 Dec 2021
Reporting date: 08 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-261185

EFFECT filing

Filing date: 26 Nov 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

424B3 File 333-261185

424B3

Filing date: 26 Nov 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-11460

8-K

Filing date: 23 Nov 2021
Reporting date: 23 Nov 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 23 Nov 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

S-1/A File 333-261185

S-1/A

Filing date: 23 Nov 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .